Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease.
- Published In:
- Bulletin of experimental biology and medicine, 171(2), 190-193 (2021)
- Authors:
- Khavinson, V Kh(3), Lin'kova, N S, Umnov, R S
- Database ID:
- RPEP-05494
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05494APA
Khavinson, V Kh; Lin'kova, N S; Umnov, R S. (2021). Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease.. Bulletin of experimental biology and medicine, 171(2), 190-193. https://doi.org/10.1007/s10517-021-05192-6
MLA
Khavinson, V Kh, et al. "Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease.." Bulletin of experimental biology and medicine, 2021. https://doi.org/10.1007/s10517-021-05192-6
RethinkPeptides
RethinkPeptides Research Database. "Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regul..." RPEP-05494. Retrieved from https://rethinkpeptides.com/research/khavinson-2021-peptide-ked-moleculargenetic-aspects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.